FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy
- 3 July 2017
- journal article
- research article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 49 (9) , 1585-1591
Abstract
We investigated the accuracy of FDG-PET/CT response identification following neoadjuvant or induction chemotherapy (NAIC) for invasive bladder cancer (BC) as to better select patients for radical cystectomy (RC).Keywords
This publication has 22 references indexed in Scilit:
- FDG-Positron Emission Tomography/Computerized Tomography for Monitoring the Response of Pelvic Lymph Node Metastasis to Neoadjuvant Chemotherapy for Bladder CancerJournal of Urology, 2013
- Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder CancerEuropean Urology, 2012
- 11C-Acetate PET/CT in Bladder Urothelial CarcinomaClinical Nuclear Medicine, 2012
- Prognostic value of lymph-node dissection in patients undergoing radical cystectomy following previous oncological treatment for bladder cancerScandinavian Journal of Urology and Nephrology, 2011
- 2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trialAnnals of Oncology, 2011
- Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder CancerJournal of Clinical Oncology, 2010
- Prospective Study of [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Staging of Muscle-Invasive Bladder CarcinomaJournal of Clinical Oncology, 2009
- POST-CHEMOTHERAPY SURGERY IN PATIENTS WITH UNRESECTABLE OR REGIONALLY METASTATIC BLADDER CANCERJournal of Urology, 2001
- Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendationsEuropean Journal of Cancer, 1999
- Positron emission tomography with L‐methyl‐ 11 C‐methionine in the monitoring of therapy response in muscle‐invasive transitional cell carcinoma of the urinary bladderBritish Journal of Urology, 1994